✦ LIBER ✦

Pemetrexed/Oxaliplatin for First-Line Treatment of Patients with Advanced Colorectal Cancer: A Phase II Trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program

✍ Scribed by James N. Atkins; Samuel A. Jacobs; H. Samuel Wieand; Roy E. Smith; William J. John; Linda H. Colangelo; Victor G. Vogel; J. Philip Kuebler; Terrence P. Cescon; Barbara J. Miller; Charles E. Geyer Jr; Norman Wolmark

Book ID: 119934994
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 107 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2005.n.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of a Doxorubicin/Docetaxe

Phase II Trial of a Doxorubicin/Docetaxel Doublet for Locally Advanced and Metastatic Breast Cancer: Results from National Surgical Adjuvant Breast and Bowel Project Trial BP-57

✍ Roy E. Smith; Stewart J. Anderson; Barry C. Lembersky; Ann Brown; Eleftherios P. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 152 KB

Alternating Systemic and Hepatic Artery

Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

✍ Alberts, S. R.; Roh, M. S.; Mahoney, M. R.; O'Connell, M. J.; Nagorney, D. M.; W 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 105 KB

Gemcitabine and oxaliplatin followed by

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase II study of pemetrexed disodium, a

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma : A study of the national cancer institute of Canada clinical trials group

✍ Frances A. Shepherd; Janet Dancey; Andrew Arnold; Alan Neville; James Rusthoven; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## Background: Pemetrexed disodium (alimta [eli lilly and company, indianapolis, in], ly231514, multitargeted antifolate) is a new multitargeted antifolate agent that inhibits multiple enzymes in the folate pathway. phase ii trials showed single-agent response rates of 16% and 23% in untreated pati

The Breast Avastin Trial: phase II study

The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer

✍ Bisagni, G.; Musolino, A.; Panebianco, M.; Matteis, A.; Nuzzo, F.; Ardizzoni, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB

Single-Agent Rituximab as First-Line and

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

✍ Hainsworth, J. D. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 73 KB